# Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant

> **NCT06163404** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Spirair, Inc** · enrollment: 102 (actual)

## Conditions studied

- Nasal Septal Deviation
- Nasal Airway Obstruction

## Interventions

- **DEVICE:** Implantation of Spirair Nasal Device using the Spirair delivery system.

## Key facts

- **NCT ID:** NCT06163404
- **Lead sponsor:** Spirair, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06163404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06163404, "Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06163404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*